Climb Bio
Latest round
- Series B
Last raised
- May 2021
Total raised
- $60M
Investors
- 6
About Climb Bio
, formerly known as Eliem Therapeutics, Inc. is a biotechnology company that develops treatments for neuronal excitability disorders. Andrew Levin and Valerie Morisset co-founded the company.50 per share, under the ticker symbol ELYM. In June 2024, Eliem Therapeutics, Inc. The company's R&D team offers therapies for central and peripheral nervous system disorders that include a variety of common conditions such as chronic pain, depression, epilepsy, and anxiety to enhance a patients’ quality of life. Eliem Therapeutics's pipeline of preclinical candidates includes ETX-810 palmitoylethanolamide (PEA) prodrug for chronic pain and ETX-155 gamma-aminobutyric acid (GABAA) positive allosteric modulator (PAM) for major depressive disorder, hormone-related mood disorders, and focal onset seizures.
Who invested in Climb Bio
6 investors across 1 round
See all investors in Climb Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 21, 2021
Amount
$60M
Investors
Questions about Climb Bio
Who invested in Climb Bio?
Climb Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Climb Bio raised?
Climb Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Climb Bio last raise money?
Climb Bio's most recent round on record is a Series B, in May 2021.
What does Climb Bio do?
, formerly known as Eliem Therapeutics, Inc.
Where is Climb Bio headquartered?
Climb Bio is headquartered in Wellesley, US.
Which VCs invest in companies like Climb Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Climb Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Climb Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.